Call for Late-Breaking Clinical Trials (LBCT)
The Late-Breaking Clinical Trials (LBCT) Forum is dedicated to presenting groundbreaking cardiovascular research with significant scientific merit and clinical impact. In collaboration with JACC and its premier sister journals, we now invite global researchers to submit their most compelling clinical studies in cardiovascular medicine. Accepted LBCT submissions will be considered for simultaneous full-text publication in JACC or its leading subspecialty journals. Submission Guidelines We welcome unpublished, high-impact clinical studies (e.g., pivotal trials, prospective RCTs, multicenter registries) that meet both criteria: 1.Planned first disclosure of primary/secondary endpoint results at QICC 2025 2. No prior publication before QICC 2025 (October 20–23) Key Features: ✓ Accepted studies will be presented at the LBCT Forum ✓ Submitters must confirm study completion (positive/negative results equally eligible) ✓ Mandatory online submission only (no email/postal submissions)
Submission Deadline Please Complete the online form by September 1, 2025
Contacts General Inquiries: Ms.Liu Shanshan | +86 195 6048 0875 Technical Support: Mr. Feng| +86 186 1006 5085 Email: sub@qiccmd.com
QICC2025 Venue: HANGZHOU INTERNATIONAL EXPO CENTER
Email: qicc@qicc.org, zjxg2010@126.com
CopyRight◎ QICC2025
京ICP备16025898号-8
